Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives

Australian and New Zealand Journal of Public Health

Volumn 39, Issue 5, 2015, Pages 441-445

  Jordan, Susan J ^a,b   Wilson, Louise F ^a   Nagle, Christina M ^a,b   Green, Adele C ^a,b,c   Olsen, Catherine M ^a,b   Bain, Christopher J ^a,d   Pandeya, Nirmala ^a,b   Whiteman, David C ^a,b   Webb, Penelope M ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d The Australian National University   (Australia)

Author keywords

cancer; infection; population attributable fraction; risk factor

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; AUSTRALIA; BREAST NEOPLASMS; CHEMICALLY INDUCED; ENDOMETRIAL NEOPLASMS; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; RISK; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUSTRALIA; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL, COMBINED; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; RISK; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84943160034     PISSN: 13260200     EISSN: 17536405     Source Type: Journal    
DOI: 10.1111/1753-6405.12444     Document Type: Article

References (20)

1. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens. Part A: Pharmaceuticals. Lyon (FRC): World Health Organisation; 2012.
2. Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO, et al., Hormonal contraception and risk of cancer. Hum Reprod Update. 2010; 16 (6): 631-50.
3. Whiteman DC, Webb PM, Green AC, Neale RE, Fritschi L, Bain CJ, et al., Cancers in Australia in 2010 attributable to modifiable factors: introduction and overview. Aust NZ J Public Health. 2015; 39: 403-7.
4. Collaborative Group on Hormonal Factors in Breast C. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 1996; 347 (9017): 1713-27.
5. International Collaboration of Epidemiological Studies of Cervical C, Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, et al., Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007; 370 (9599): 1609-21.
6. Collaborative Group on Epidemiological Studies of Ovarian C, Beral V, Doll R, Hermon C, Peto R, Reeves G,. Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet. 2008; 371 (9609): 303-14.
7. Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, et al., Reproductive risk factors and endometrial cancer: The European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010; 127 (2): 442-51.
8. Australian Bureau of Statistics. 2001 National Health Survey Expanded CURF, RADL. Findings Based on Use of ABS CURF Data. Canberra (AUST): ABS; 2001.
9. Australian Bureau of Statistics. 4363.0.55.001-National Health Survey: User's Guide 2001 [Internet]. Canberra (AUST): ABS; 2003 [cited 2013 Feb 2]. Available from: http://www.abs.gov.au/Ausstats/absatnsf/Previousproducts/4363.0.55.001Contents12001?opendocument&tabname=Summary&prodno=4363.0.55.001&issue=2001&num=&view=
10. Gray E, McDonald, P,. Using a reporductive life course approach to understand contraceptive method use in Australia. J Biosoc Sci. 2010; 42 (1): 43-57.
11. Department of Health and Ageing. Australian Statistics on Medicine 2010. Canberra (AUST): Commonwealth of Australia; 2012.
12. Olsen CM, Bain CJ, Jordan SJ, Nagle CM, Green AC, Whiteman DC, et al., Recreational physical activity and epithelial ovarian cancer: A case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2007; 16 (11): 2321-30.
13. Australian Institute of Health and Welfare. Cancer Data. Pivot Table [Internet]. Canberra (AUST): ABS; 2015 [cited 2014 Jun 23]. Available from: http://www.aihw.gov.au/cancer-data/
14. Parkin DM,. Cancers attributable to exposure to hormones in the UK in 2010. Br J Cancer. 2011; 105 Suppl 2: 42-8.
15. International Agency for Research on Cancer Working Group. Attributable Causes of Cancer in France in the Year 2000. IARC Working Group Reports 3. Lyon (FRC): World Health Organization; 2007.
16. Pike MC, Spicer DV,. Hormonal contraception and chemoprevention of female cancers. Endocr Relat Cancer. 2000; 7 (2): 73-83.
17. Cramer D, Welch WR,. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst. 1983; 71 (4): 717-21.
18. Risch H,. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998; 90 (23): 1774-86.
19. Fathalla MF,. Incessant ovulation-a factor in ovarian neoplasia? Lancet. 1971; 2 (7716): 163.
20. Mazza D, Harrison C, Taft A, Brijnath B, Britt H, Hobbs M, et al., Current contraceptive management in Australian general practice: An analysis of BEACH data. Med J Aust. 2012; 197 (2): 110-4.